High-sensitivity C-reactive protein predicts 10-year cardiovascular outcome after percutaneous coronary intervention

EuroIntervention 2016;12:345-351 published online ahead of print July 2015. DOI: 10.4244/EIJY15M07_04

Rohit M. Oemrawsingh
Rohit M. Oemrawsingh1, MD; Jin M. Cheng1, MD; K. Martijn Akkerhuis1, MD, PhD; Isabella Kardys1, MD, PhD; Muzaffer Degertekin2, MD, PhD; Robert-Jan van Geuns1, MD, PhD; Joost Daemen1, MD, PhD; Eric Boersma1, PhD, MSc; Patrick W. Serruys1, MD, PhD; Ron T. van Domburg1*, PhD
1. Department of Cardiology, Erasmus MC, Rotterdam, The Netherlands; 2. Department of Cardiology, Yeditepe University Hospital, Istanbul, Turkey

Aims: This study aimed to evaluate the prognostic value of high-sensitivity C-reactive protein (hsCRP) during 10-year follow-up after percutaneous coronary intervention (PCI).

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

c-reactive proteinpercutaneous coronary interventionprognosis
Coronary interventionsSTEMINSTEMIStable CAD
Read next article
Evaluation of a crystalline sirolimus-eluting coronary stent with a bioabsorbable polymer designed for rapid dissolution: two-year outcomes from the DESSOLVE I and II trials

Latest news